Skip to main navigation
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Contact
  • Pipeline
    • Overview
    • Herpesviruses
    • Viral Hepatitis
    • Research & Discovery
    • Publications
  • Patients
    • Commitment
    • Resources
    • Clinical Studies
  • Sustainability
    • Overview
    • Business Ethics
    • Access to Health Care
    • Human Capital
    • Environment, Health & Safety
  • Collaborations
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
  • Careers
    • Culture
    • Benefits
    • Opportunities
On the
  • Press Releases
  • Events & Presentations

Event Details

49th Annual International Herpesvirus Workshop

Jul 26 - Jul 30, 2025

Supporting Materials

ABI-5366 and ABI-1179, Two Potent, Long-Acting Helicase Primase Inhibitors for the Treatment of Recurrent Genital Herpes 735 KB
ABI-5366 and ABI-1179, Two Potent, Long-Acting Helicase Primase Inhibitors for the Treatment of Recurrent Genital Herpes (Oral Presentation) 562.2 KB
Shareholder Tools Print Email Alerts RSS News Feeds
Search Investors

Contact Us

Contact Us

833.509.4583 info@assemblybio.com LinkedIn
AssemblyBio logo
 
Privacy Notice Cookie Policy

© 2026 Assembly Biosciences, Inc.